ZenOnco.io, an oncology healthcare platform, has raised $1.4 million in a seed round led by Enzia Ventures, with Better Capital, Apollo Hospitals, Titan Capital, Dr Arvind Kumar, and other angel investors participating.
According to a news statement from ZenOnco.io, the funds will be used to expand the company’s current activities and introduce new products.
ZenOnco.io was founded in 2019 by Dimple Parmar and Kishan Shah with the goal of improving cancer patients’ quality of life and extending their lives through integrated oncology care, which incorporates both medical and alternative treatments.
A team of onco-nutritionists, onco-psychologists, and physiotherapists work on the platform to assist cancer patients with side effects and symptom management in order to improve their quality of life.